Skip to content

VAPOTHERM INC

Delisted

CIK 1253176fmd_0E5X96X7BBMVKRT62JQ1SC2QJ3Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2018 to Jun 30, 2024, 26 periods

Latest annual · FY2023

Millions
Total revenues
69
Gross profit
28
Operating income
(39)
Net income
(58)
Free cash flow
(27)

Latest quarter · Q2 FY2024

Millions
Total revenues
17
Gross profit
8
Operating income
(9)
Net income
(14)
Free cash flow
(5)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2020 to FY2023
-18.3%
Revenue, 5 yearsFY2018 to FY2023
+10.1%
Net income, 5 yearsFY2018 to FY2023
n/m

VAPOTHERM INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2023FY2022ChangeSource
Revenue$68.7 million$66.8 million+2.8%10-K 2024-02-22 · proof
Gross profit$28.3 million$17.2 million+64%10-K 2024-02-22 · proof
Operating income-$39.1 million-$100.4 million10-K 2024-02-22 · proof
Net income-$58.2 million-$113.3 million10-K 2024-02-22 · proof
Cash from operating activities-$24.3 million-$80.2 million10-K 2024-02-22 · proof
Free cash flow-$27.3 million-$91.8 million10-K 2024-02-22 · proof
Total assets$77.6 million$96.2 million-19.3%10-K 2024-02-22 · proof
Total liabilities$133 million$124.4 million+6.9%10-K 2024-02-22 · proof
Cash and cash equivalents$9.7 million$15.7 million-38.2%10-K 2024-02-22 · proof
What was VAPOTHERM INC's revenue in fiscal 2023?
VAPOTHERM INC reported revenue of $68.7 million for fiscal 2023 (the year ended Dec 31, 2023), against $66.8 million the year before (+2.8%). Source: the 10-K filed with the SEC on Feb 22, 2024. SEC
What was VAPOTHERM INC's gross profit in fiscal 2023?
VAPOTHERM INC reported gross profit of $28.3 million for fiscal 2023 (the year ended Dec 31, 2023), against $17.2 million the year before (+64%). Source: the 10-K filed with the SEC on Feb 22, 2024. SEC
What was VAPOTHERM INC's operating income in fiscal 2023?
VAPOTHERM INC reported operating income of -$39.1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$100.4 million the year before. Source: the 10-K filed with the SEC on Feb 22, 2024. SEC
What was VAPOTHERM INC's net income in fiscal 2023?
VAPOTHERM INC reported net income of -$58.2 million for fiscal 2023 (the year ended Dec 31, 2023), against -$113.3 million the year before. Source: the 10-K filed with the SEC on Feb 22, 2024. SEC
What was VAPOTHERM INC's cash from operating activities in fiscal 2023?
VAPOTHERM INC reported cash from operating activities of -$24.3 million for fiscal 2023 (the year ended Dec 31, 2023), against -$80.2 million the year before. Source: the 10-K filed with the SEC on Feb 22, 2024. SEC
What was VAPOTHERM INC's free cash flow in fiscal 2023?
VAPOTHERM INC reported free cash flow of -$27.3 million for fiscal 2023 (the year ended Dec 31, 2023), against -$91.8 million the year before. Source: the 10-K filed with the SEC on Feb 22, 2024. SEC
What are VAPOTHERM INC's total assets?
As of Dec 31, 2023, VAPOTHERM INC reported total assets of $77.6 million, against $96.2 million a year earlier (-19.3%). Source: the 10-K filed with the SEC on Feb 22, 2024. SEC
What are VAPOTHERM INC's total liabilities?
As of Dec 31, 2023, VAPOTHERM INC reported total liabilities of $133 million, against $124.4 million a year earlier (+6.9%). Source: the 10-K filed with the SEC on Feb 22, 2024. SEC
What are VAPOTHERM INC's cash and cash equivalents?
As of Dec 31, 2023, VAPOTHERM INC reported cash and cash equivalents of $9.7 million, against $15.7 million a year earlier (-38.2%). Source: the 10-K filed with the SEC on Feb 22, 2024. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1253176&period_type=annual&limit=5"

Information only, not investment advice.